SD

Sagar Devram Shinde

Active Director Director DIN 09729038
DIN 09729038 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Sagar Devram Shinde

Data last updated:

Sagar Devram Shinde is a Director at Metagen Pharmaceutical Private Limited (since 2022). The company operates in Pharma.

DIN 09729038
Primary Designation Director
Industry Pharma
First Appointment 07 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Sep 20222022Active

Directorship timeline

Open interactive timeline →
Metagen Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sagar Devram Shinde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagar Devram Shinde

Sagar Devram Shinde currently holds 1 directorship: Metagen Pharmaceutical Private Limited (Director, since 07 Sep 2022).

Sagar Devram Shinde was first appointed on 07 Sep 2022 as Director at Metagen Pharmaceutical Private Limited.

The current boards of Sagar Devram Shinde's companies include Amey Vikas Patil (Metagen Pharmaceutical Private Limited), Atul Chandrakant Pimple (Metagen Pharmaceutical Private Limited), Janvi Jayesh Patil (Metagen Pharmaceutical Private Limited), Kiran Arun More (Metagen Pharmaceutical Private Limited), Peter Philip Fernandes (Metagen Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available